BRPI0922714A2 - composto, processo para preparar um compsoto, medicamento, uso de um composto, e, composição farmacêutica - Google Patents

composto, processo para preparar um compsoto, medicamento, uso de um composto, e, composição farmacêutica

Info

Publication number: BRPI0922714A2
Authority: BR; Brazil
Prior art keywords: compound; drug; preparing; pharmaceutical composition; pharmaceutical
Prior art date: 2008-12-12

Application number

BRPI0922714A

Other languages

English (en)

Inventor

Elmar Wegener

Josephus H M Lange

Konrad F Koehler

Michael Mlinaric

Pieter Smid

Sara Nunez-Garcia

Original Assignee

Abbott Healthcare Products Bv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-12-12

Filing date

2009-12-10

Publication date

2016-01-05

2009-12-10 Application filed by Abbott Healthcare Products Bv filed Critical Abbott Healthcare Products Bv

2016-01-05 Publication of BRPI0922714A2 publication Critical patent/BRPI0922714A2/pt

Links

150000001875 compounds Chemical class 0.000 title 3
239000003814 drug Substances 0.000 title 1
229940079593 drug Drugs 0.000 title 1
238000004519 manufacturing process Methods 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/10—Spiro-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Immunology (AREA)
Diabetes (AREA)
Obesity (AREA)
Hematology (AREA)
Rheumatology (AREA)
Endocrinology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Emergency Medicine (AREA)
Child & Adolescent Psychology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Transplantation (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Dermatology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

BRPI0922714A 2008-12-12 2009-12-10 composto, processo para preparar um compsoto, medicamento, uso de um composto, e, composição farmacêutica BRPI0922714A2 (pt)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US12191308P	2008-12-12	2008-12-12
EP08171421		2008-12-12
PCT/EP2009/066836 WO2010066840A1 (en)	2008-12-12	2009-12-10	SPIRO AZEPANE-OXAZOLIDINONES AS Kv1.3 POTASSIUM CHANNEL BLOCKERS

Publications (1)

Publication Number	Publication Date
BRPI0922714A2 true BRPI0922714A2 (pt)	2016-01-05

Family

ID=40513443

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0922714A BRPI0922714A2 (pt)	2008-12-12	2009-12-10	composto, processo para preparar um compsoto, medicamento, uso de um composto, e, composição farmacêutica

Country Status (20)

Country	Link
US (1)	US8575148B2 (pt)
EP (1)	EP2376501A1 (pt)
JP (1)	JP2012511546A (pt)
KR (1)	KR20110110165A (pt)
CN (1)	CN102333782A (pt)
AR (1)	AR074558A1 (pt)
AU (1)	AU2009324358A1 (pt)
BR (1)	BRPI0922714A2 (pt)
CA (1)	CA2743557A1 (pt)
CO (1)	CO6390036A2 (pt)
CR (1)	CR20110302A (pt)
DO (1)	DOP2011000164A (pt)
EA (1)	EA201170801A1 (pt)
EC (1)	ECSP11011118A (pt)
IL (1)	IL212948A0 (pt)
MX (1)	MX2011006221A (pt)
PE (1)	PE20110772A1 (pt)
TW (1)	TW201026708A (pt)
WO (1)	WO2010066840A1 (pt)
ZA (1)	ZA201104041B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IN2014CN03333A (pt)	2011-10-03	2015-07-03	Univ California
EA026161B1 (ru) *	2012-10-29	2017-03-31	Ф. Хоффманн-Ля Рош Аг	Производные 3,4-дизамещенного оксазолидинона и их применение в качестве ингибиторов кальций-активируемых калиевых каналов
TWI701249B (zh)	2015-03-13	2020-08-11	德商４Ｓｃ製藥公司	Ｋv１.３抑制劑及其醫學應用
TWI698438B (zh)	2015-03-13	2020-07-11	德商４Ｓｃ製藥公司	Ｋv１.３抑制劑及其醫學應用
CN109053751A (zh) *	2018-08-30	2018-12-21	成都海博锐药业有限公司	具有螺环结构的fxr调节剂
WO2020252130A1 (en) *	2019-06-12	2020-12-17	Lieber Institute, Inc.	Kv11.1-3.1 inhibiting methods and compositions
IL291867A (en) *	2019-10-07	2022-06-01	De Shaw Res Llc	Heterocyclic aryl compounds as Shaker kv1.3 potassium channel blockers
WO2021071812A1 (en) *	2019-10-07	2021-04-15	D.E Shaw Research, Llc	Arylmethylene heterocyclic compounds as kv1.3 potassium shaker channel blockers
KR20220079878A (ko) *	2019-10-07	2022-06-14	디.이. 쇼우 리서치, 엘엘씨	Kv1.3 칼륨 셰이커 채널 차단제로서의 아릴 헤테로비시클릭 화합물
CN111574537B (zh) *	2020-05-20	2022-11-15	成都药明康德新药开发有限公司	叔丁基-8-氧杂-3,11-二氮杂螺[5.6]十二烷-3-甲酸基酯的合成方法
CA3235270A1 (en) *	2021-10-13	2023-04-20	Vanqua Bio, Inc.	Small molecule modulators of glucocerebrosidase activity and uses thereof
JP2026513122A (ja) *	2022-10-28	2026-04-23	上海深勢唯思科技有限責任公司	芳香族複素環式Ｋｖ１．３阻害剤、その製造方法及び用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6303637B1 (en)	1998-10-30	2001-10-16	Merck & Co., Inc.	Heterocyclic potassium channel inhibitors

2009
- 2009-12-09 TW TW098142079A patent/TW201026708A/zh unknown
- 2009-12-09 AR ARP090104760A patent/AR074558A1/es unknown
- 2009-12-10 EA EA201170801A patent/EA201170801A1/ru unknown
- 2009-12-10 EP EP09765127A patent/EP2376501A1/en not_active Withdrawn
- 2009-12-10 US US13/133,042 patent/US8575148B2/en not_active Expired - Fee Related
- 2009-12-10 MX MX2011006221A patent/MX2011006221A/es not_active Application Discontinuation
- 2009-12-10 AU AU2009324358A patent/AU2009324358A1/en not_active Abandoned
- 2009-12-10 WO PCT/EP2009/066836 patent/WO2010066840A1/en not_active Ceased
- 2009-12-10 JP JP2011540106A patent/JP2012511546A/ja active Pending
- 2009-12-10 CA CA2743557A patent/CA2743557A1/en not_active Abandoned
- 2009-12-10 CN CN2009801494792A patent/CN102333782A/zh active Pending
- 2009-12-10 BR BRPI0922714A patent/BRPI0922714A2/pt not_active IP Right Cessation
- 2009-12-10 KR KR1020117016047A patent/KR20110110165A/ko not_active Withdrawn
- 2009-12-10 PE PE2011001198A patent/PE20110772A1/es not_active Application Discontinuation
2011
- 2011-05-17 IL IL212948A patent/IL212948A0/en unknown
- 2011-05-31 ZA ZA2011/04041A patent/ZA201104041B/en unknown
- 2011-05-31 DO DO2011000164A patent/DOP2011000164A/es unknown
- 2011-06-03 CR CR20110302A patent/CR20110302A/es not_active Application Discontinuation
- 2011-06-08 CO CO11070889A patent/CO6390036A2/es not_active Application Discontinuation
- 2011-06-09 EC EC2011011118A patent/ECSP11011118A/es unknown

Also Published As

Publication number	Publication date
ZA201104041B (en)	2012-11-28
JP2012511546A (ja)	2012-05-24
ECSP11011118A (es)	2011-07-29
MX2011006221A (es)	2011-06-28
US8575148B2 (en)	2013-11-05
CR20110302A (es)	2011-10-27
AU2009324358A1 (en)	2011-06-23
EP2376501A1 (en)	2011-10-19
CA2743557A1 (en)	2010-06-17
KR20110110165A (ko)	2011-10-06
US20110237569A1 (en)	2011-09-29
DOP2011000164A (es)	2011-06-30
TW201026708A (en)	2010-07-16
WO2010066840A1 (en)	2010-06-17
CN102333782A (zh)	2012-01-25
CO6390036A2 (es)	2012-02-29
PE20110772A1 (es)	2011-10-19
EA201170801A1 (ru)	2011-12-30
IL212948A0 (en)	2011-07-31
AR074558A1 (es)	2011-01-26

Similar Documents

Publication	Publication Date	Title
BRPI0906475A2 (pt)	2015-07-14	Compostos, processso para a preparação de um composto, composição farmacêutica e uso de um composto
BRPI1006162A2 (pt)	2019-09-24	"composto,processo para preparar um composto,formulação farmacêutica,e uso de um composto".
BRPI0818533A2 (pt)	2017-06-06	composto, composição farmacêutica, e, processo para a preparação de um composto
BRPI0816331A2 (pt)	2015-04-14	Composto, uso de um composto, composição farmacêutica, e, processo para preparar um composto.
BRPI0914927A2 (pt)	2017-06-20	composto, composição farmacêutica, métodos para inibir a função de fak e de tratamento de um câncer, uso de um composto, e, processo para preparar um composto
BRPI0909691A8 (pt)	2018-01-02	composto, método para preparar um composto, e, composição farmacêutica
BRPI0908738A2 (pt)	2017-06-13	composto, medicamento, uso de um composto, e, processo para preparar os compostos
BRPI0912348A2 (pt)	2015-10-13	composto de 3-aminocarbazol, composição farmacêutica, método para preparar um composto de 3-aminocarbazol, uso de um composto de 3-aminocarbazol, e, método para tratar ou prevenir doenças
BRPI0919942A2 (pt)	2014-12-23	Composto, composição farmacêutica, e, uso de um composto
BRPI0907562A2 (pt)	2017-05-23	composto, composição farmacêutica, e, uso de um composto
BRPI0921375A2 (pt)	2015-12-29	composto, composição farmacêutica, e, uso de um composto
BR112012016201A2 (pt)	2017-12-19	''composto, processo para a preparação de um composto, composição farmacêutica e uso de um composto''
BRPI0817423A2 (pt)	2015-06-16	Processos para a preparação de um composto, para a preparação de uma formulação farmacêutica, e para a preparação de um intermediário de um composto, e, composto
BRPI0908252A2 (pt)	2015-07-21	Processo para preparar um composto, e, uso de um composto
BRPI0917579A2 (pt)	2016-10-11	composto, composição farmacêutica, métodos, e, uso de um composto
BR112012008485A2 (pt)	2019-09-24	composto, formulação farmacêutica, uso de um composto, processo para a fabricação do composto de formula e compostos, processos, formulações e usos
BRPI0822946A2 (pt)	2015-06-23	Derivado de carboxiamida, processo para preparação de derivado de carboxiamida, composição farmacêutica e uso do derivado de carboxiamida
BRPI0921879A2 (pt)	2018-10-16	composto, composição farmacêutica , e, uso de um composto
BR112013008008A2 (pt)	2016-06-21	composto, composição farmacêutica e processo para preparar um composto
BR112013028959A2 (pt)	2016-08-30	composto, processo para o preparo de um composto, combinação de um composto, composição farmacêutica, uso de um composto, dispositivo e kit
BRPI0815493A2 (pt)	2015-02-10	Composto, uso de um composto, composição faramcêutica, método para a terapia de dor, e, processo para preparar um composto.
BRPI0811275A2 (pt)	2014-12-23	Composto, processo para a preparação do mesmo, composição farmacêutica, uso de composto, e, método para tratar doença
BRPI0817889A2 (pt)	2015-03-31	Composição farmacêutica, composto misto de metal para uso como um medicamento, uso de um composto misto de metal, e, processo para a produção de um composto misto de metal esgotado de magnésio
BRPI0814821A2 (pt)	2015-02-03	Composto, composição farmacêutica, e, processo para preparar um composto
BRPI0906937A2 (pt)	2016-04-19	composto, composição farmacêutica, e, uso de um composto

Legal Events

Date	Code	Title	Description
2016-07-19	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE AS 4A, 5A E 6A ANUIDADES.
2016-11-01	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2376 DE 19-07-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.